Corporate News 03-Nov-23
Marksans Pharma arm receives EIR from USFDA
Marksans Pharma announced that its wholly owned subsidiary Time-Cap Laboratories, Inc. has received Establishment Inspection Report (ErR) from US Food & Drugs Administration for the audit conducted in October 2023. No 483' s were issued during the Audit.
Previous News
Marksans Pharma receives affirmation in credit ratings from CARE
( Corporate News - 12-Oct-23 14:30 )
Marksans Pharma spurts on buying Tevapharm's bulk formulations biz
( Hot Pursuit - 12-Oct-22 09:36 )
Marksans Pharma AGM scheduled
( Corporate News - 04-Aug-23 11:09 )
Marksans Pharma declare Quarterly Result
( Corporate News - 13-May-24 15:04 )
Marksans Pharma consolidated net profit declines 3.87% in the June 2022 quarter
( Results - Announcements 14-Aug-22 14:22 )
Marksans Pharma to convene board meeting
( Corporate News - 29-Jan-20 16:22 )
Marksans Pharma standalone net profit declines 88.78% in the March 2017 quarter
( Results - Announcements 29-May-17 17:06 )
Marksans Pharma commences buyback of shares
( Corporate News - 15-Jul-22 17:50 )
Marksans Pharma standalone net profit declines 59.19% in the June 2019 quarter
( Results - Announcements 10-Aug-19 11:48 )
Nifty below 17,400 level; bank stocks under pressure
( Market Commentary - Mid-Session 10-Mar-23 14:37 )
Marksans Pharma to conduct board meeting
( Corporate News - 03-Feb-23 18:58 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top
